FDA NDC Directory · JSON-LD · Markdown

Lantus

NDC 0088-2220 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin glargine
Labeler / Manufacturersanofi-aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA021081
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN GLARGINE (100 [iU]/mL)
Marketing started20090923
Package count2

External sources

Source: openFDA. Public-domain (CC0).